Subcutaneous Clinical Trials

12 recruitingLast updated: July 25, 2026

There are 12 actively recruiting subcutaneous clinical trials across 12 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3. Top locations include Boston, Massachusetts, United States, New Haven, Connecticut, United States, Duarte, California, United States. Updated daily from ClinicalTrials.gov.


Subcutaneous Trials at a Glance

12 actively recruiting trials for subcutaneous are listed on ClinicalTrialsFinder across 6 cities in 12 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Boston, New Haven, and Duarte. Lead sponsors running subcutaneous studies include Anova Enterprises, Inc, Caliway Biopharmaceuticals Australia Pty Ltd, and Ankyra Therapeutics, Inc.

Browse subcutaneous trials by phase

Treatments under study

About Subcutaneous Clinical Trials

Looking for clinical trials for Subcutaneous? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Subcutaneous trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Subcutaneous clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Phase 3

Subcutaneous Calcitonin in Acute Herpes Zoster

CalcitoninAcute Herpes ZosterSubcutaneous
Tanta University168 enrolled1 locationNCT07655804
Recruiting
Phase 1Phase 2

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

Aggressive NK-cell LeukemiaLGLL - Large Granular Lymphocytic LeukemiaPrimary Cutaneous Gamma-Delta T-Cell Lymphoma+10 more
Dren Bio200 enrolled37 locationsNCT05475925
Recruiting
Phase 2

A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat

Subcutaneous Fat
Caliway Biopharmaceuticals Co., Ltd.250 enrolled1 locationNCT07608770
Recruiting

A Registry for People With T-cell Lymphoma

T-cell LymphomaNK-Cell LymphomaT-cell Prolymphocytic Leukemia+27 more
Memorial Sloan Kettering Cancer Center1,000 enrolled26 locationsNCT05978141
Recruiting
Not Applicable

Effectiveness of a Zinc Oxide Adhesive Securement Device in the Fixation of Midline and Peripherally Inserted Central Catheters in Hospitalized Adult Patients

PhlebitisPainVascular Access Complication+1 more
Hospital Arnau de Vilanova400 enrolled2 locationsNCT06770374
Recruiting
Phase 1

Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors

Advanced Solid TumorMetastatic Solid TumorNon-small Cell Lung Cancer+6 more
Ankyra Therapeutics, Inc97 enrolled5 locationsNCT06171750
Recruiting
Not Applicable

Nutritional Oleic Acid Modulation of adIpose Cholesterol Metabolism in Patients Living With Obesity

ObesityVisceral Adipose TissueWhite Adipose Tissue Inflammation+1 more
Nantes University Hospital40 enrolled1 locationNCT07027033
Recruiting
Not Applicable

Reduction of Myopotential Interference With Smart Pass in S-ICD Patients

Subcutaneous ICDMyopotential Interference
Medical University of South Carolina71 enrolled1 locationNCT05766943
Recruiting
Not Applicable

Change of Adipose Tissues and Triglyceride After Bariatric Surgery or Life-style Intervention

Diabetes MellitusInsulin ResistanceMetabolic Disease+4 more
Chinese University of Hong Kong80 enrolled1 locationNCT03875625
Recruiting
Not Applicable

The Effect of Chilled Needle on the Development of Pain and Ecchymosis in Subcutaneous Injection in Adults

PainEcchymosisA Randomized Controlled Trial+1 more
TC Erciyes University60 enrolled1 locationNCT06222216
Recruiting

AnovaOS Network Powered Patient Registry

NeoplasmsDiseases of the Circulatory SystemInfectious Disease+18 more
Anova Enterprises, Inc100,000 enrolled1 locationNCT05013944
Recruiting
Phase 2

A Phase 2a Study to Evaluate the Preliminary Efficacy and Safety of CBL-514 Injection on Convexity or Fullness of Abdominal Subcutaneous Fat in Healthy Volunteers

Healthy subjects with undesirable subcutaneous fat thickness in belly
Caliway Biopharmaceuticals Australia Pty Ltd66 enrolled1 locationACTRN12619001580167